1. August 2014

Postdoctoral Fellowship from Carl-Zeiss-Foundation

Dr. Roman Fischer receives funding for "TNFR2-selective agonists to treat inflammatory degenerative diseases”

Successful project aquisition

 

Dr. Roman Fischer receives Postdoctoral Fellowship from Carl-Zeiss-Foundation

As of August 1st, 2014, Roman Fischer will receive funding over a period of two years from the Carl-Zeiss-Foundation. The funded project "TNFR2-selective agonists to treat inflammatory degenerative diseases” focuses on the investigation of the regenerative mechanisms of TNFR2 signaling and the development of new TNFR2-selective agonists for the future use as possible therapeutics.

Zum Seitenanfang